Upgrade to SI Premium - Free Trial

Jazz Pharmaceuticals (JAZZ) PT Raised to $202 at Goldman Sachs

March 2, 2022 6:21 AM
Goldman Sachs analyst Madhu Kumar ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles